NCT02482571

Brief Summary

The primary objective of this research is to measure changes in neurochemical concentrations during stimulation of the primary visual cortex, in both conditions of normoxia (normal oxygen availability) and induced mild hypoxia (reduced oxygen availability).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 23, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 26, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

August 13, 2015

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 26, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 26, 2016

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

May 24, 2018

Completed
Last Updated

March 19, 2019

Status Verified

March 1, 2019

Enrollment Period

1.1 years

First QC Date

June 23, 2015

Results QC Date

March 21, 2018

Last Update Submit

March 11, 2019

Conditions

Keywords

Functional MRSGlutamate

Outcome Measures

Primary Outcomes (2)

  • Change in Glutamate Concentration During a Visual Stimulus Measured by fMRS at Normoxia

    Relative change in glutamate concentration from rest to visual stimulation as measured by fMRS (with water suppression) in the primary visual cortex during conditions of normoxia.

    Baseline and Visual Stimulation at 4 minutes

  • Change in Glutamate Concentration During a Visual Stimulus Measured by Functional MRS at Hypoxia

    Relative change in glutamate concentration from rest to visual stimulation as measured by fMRS (with water suppression) in the primary visual cortex during conditions of hypoxia.

    Baseline and Visual Stimulation at 4 minutes

Secondary Outcomes (2)

  • Brain Activity Measured by Blood Oxygenation Level Dependent (BOLD) Signal at Normoxia

    Baseline and Visual Stimulation at 30 seconds

  • Brain Activity Measured by Blood Oxygenation Level Dependent (BOLD) Signal at Hypoxia

    Baseline and Visual Stimulation at 30 seconds

Study Arms (1)

Mild Hypoxia

EXPERIMENTAL

Subjects are exposed to an intervention that controls the composition of breathed air by using a gas blender (RespirAct). Subjects undergo MRI and MRS while breathing air with both normal oxygen concentration (normoxia) and reduced oxygen concentration (mild hypoxia).

Device: Mild Hypoxia

Interventions

During normoxia, the computer-controlled gas blender provides a gas mixture that generates pressures of expired O2 and CO2 similar to the resting values measured for each subject (32-35mmHg and 100-110 mmHg, respectively). During mild hypoxia, we will target the same expired CO2 of normoxia and a 60 mmHg reduction of expired O2 from the resting value (to a minimum limit of 50 mmHg), which is expected to reduce arterial oxygen saturation to 82-85%. In mild hypoxia, the fraction of inspired oxygen is reduced from \~21% (room air) to \~12% (equivalent to an altitude of 4000 meters). During both conditions of normoxia and mild hypoxia, the brain activity of subjects is monitored with functional magnetic resonance spectroscopy (fMRS) while they are presented with visual stimuli.

Mild Hypoxia

Eligibility Criteria

Age18 Years - 40 Years
Sexmale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may not qualify if:

  • Subjects with any type of bio-implant activated by mechanical, electronic, or magnetic means (e.g. cochlear implants, pacemakers, neurostimulators, biostimulators, electronic infusion pumps, etc.).
  • Subjects with any type of ferromagnetic bio-implant that could potentially be displaced or damaged, such as aneurysm clips, metallic skull plates, etc.
  • Females.
  • Subjects that exhibit noticeable anxiety and/or claustrophobia.
  • Subjects who cannot adhere to the experimental protocol for any reason.
  • Subjects who have cardiac or known circulatory impairment, and/or the inability to perspire (poor thermoregulatory function).
  • Subjects who have known conditions which can lead to emergency medical care.
  • Been diagnosed by a physician as having a psychiatric disorder, substance abuse, neurological, cardiovascular.
  • Been diagnosed by a physician as having respiratory diseases.
  • Had a brain tumor or stroke.
  • Started taking chemotherapy or immunomodulatory agents, or had any radiation treatment that could affect the brain.
  • Had two or more seizures, or been given a diagnosis of epilepsy.
  • Gotten a non-removable piercing or permanent eyeliner.
  • Had a head injury that caused you to lose consciousness for more than 30 minutes or have amnesia for more than 24 hours.
  • Anyone with a history of sleep apnea or head trauma that may have caused Traumatic Brain Injury (TBI).
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Magnetic Resoance Research, University of Minnesota

Minneapolis, Minnesota, 55455, United States

Location

Related Publications (2)

  • Ho YC, Vidyasagar R, Shen Y, Balanos GM, Golay X, Kauppinen RA. The BOLD response and vascular reactivity during visual stimulation in the presence of hypoxic hypoxia. Neuroimage. 2008 Jun;41(2):179-88. doi: 10.1016/j.neuroimage.2008.02.048. Epub 2008 Mar 6.

    PMID: 18396415BACKGROUND
  • Tuunanen PI, Murray IJ, Parry NR, Kauppinen RA. Heterogeneous oxygen extraction in the visual cortex during activation in mild hypoxic hypoxia revealed by quantitative functional magnetic resonance imaging. J Cereb Blood Flow Metab. 2006 Feb;26(2):263-73. doi: 10.1038/sj.jcbfm.9600186.

    PMID: 16079793BACKGROUND

Related Links

MeSH Terms

Conditions

Hypoxia, Brain

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesHypoxiaSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Silvia Mangia, PhD
Organization
University of Minnesota

Study Officials

  • Silvia Mangia, PhD

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 23, 2015

First Posted

June 26, 2015

Study Start

August 13, 2015

Primary Completion

September 26, 2016

Study Completion

September 26, 2016

Last Updated

March 19, 2019

Results First Posted

May 24, 2018

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share

Locations